TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, TOP-RANKED INVESTOR RIGHTS COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, TOP-RANKED INVESTOR RIGHTS COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

Rosen Law Firm is notifying investors of a potential securities class action against MoonLake Immunotherapeutics regarding allegedly false statements about their Nanobody technology and its clinical benefits during the period of March 10, 2024 to September 29, 2025.

Insights
BRK.B   neutral

Preparing for leadership transition with Greg Abel, maintaining active investment strategy despite Buffett's upcoming retirement


MLTX   negative

The lawsuit alleges the company made false and misleading statements about their Nanobody technology's clinical benefits, suggesting potential misrepresentation of their product's capabilities